Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
6.41
+0.24 (3.89%)
At close: Feb 21, 2025, 4:00 PM
6.40
-0.01 (-0.16%)
After-hours: Feb 21, 2025, 4:54 PM EST
Coya Therapeutics Employees
Coya Therapeutics had 8 employees as of December 31, 2023. The number of employees increased by 2 or 33.33% compared to the previous year.
Employees
8
Change (1Y)
2
Growth (1Y)
33.33%
Revenue / Employee
$1,194,289
Profits / Employee
-$1,337,380
Market Cap
107.09M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8 | 2 | 33.33% |
Dec 31, 2022 | 6 | 0 | - |
Dec 31, 2021 | 6 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
COYA News
- 15 days ago - Coya Therapeutics Now Pivots Toward Phase 2 In ALS And FTD - Seeking Alpha
- 15 days ago - Coya: A Few Catalysts On The Way For COYA-302 Makes This A Must Watch - Seeking Alpha
- 16 days ago - Coya Therapeutics' Alzheimer's Candidate Shows Improved Inflammatory Blood Markers Following Monthly Dosing - Benzinga
- 16 days ago - Coya Therapeutics Reports Statistically Significant Improvement of Inflammatory Blood Markers in Patients with Alzheimer's Disease Following Monthly Dosing with Low-Dose IL-2, Further Supporting Clinical Development - Business Wire
- 18 days ago - Coya Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire
- 4 weeks ago - Coya Therapeutics Announces Pipeline Expansion - COYA 303: COYA 301 in Combination with GLP-1 Receptor Agonist for the Treatment of Inflammatory Diseases - Business Wire
- 2 months ago - Coya Therapeutics Provides Enrollment Update of the Investigator-Initiated Phase 1 Study of Low Dose Interleukin-2 (LD IL-2) + CTLA4-Ig Fusion Protein in Patients with Frontotemporal Dementia (FTD) - Business Wire
- 3 months ago - Coya Therapeutics to Participate in a Fireside Chat at the 7th Annual Evercore HealthCONx Conference - Business Wire